MDT

Late-Breaking Clinical Trial Results Show Medtronic-Exclusive Pacemaker Algorithm Significantly Delays Atrial Fibrillation

[Thomson Reuters ONE] – MINERVA Trial Presented at Heart Rhythm Meeting Shows Medtronic Advanced Pacing Features Reduce the Progression of Persistent AF by 58 Percent While Reducing AF-Related Hospital Visits That Lead to Increased … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here to […]

New Data Show That Defibrillators Programmed to Wait Longer to Deliver Therapy Are Safe for Secondary Prevention ICD Patients with Medtronic SmartShock Technology

[Thomson Reuters ONE] – Late-breaking Clinical Trial Data Confirm Industry Leadership with 1 Percent Inappropriate Shocks Using Medtronic SmartShock Technology MINNEAPOLIS and SAN FRANCISCO – May 10, 2014 – Medtronic, Inc. (NYSE: … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here to view […]

Medtronic Announces 2014 Analyst Meeting and Webcast

[Thomson Reuters ONE] – MINNEAPOLIS – May 9, 2014 – Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Thursday, June 5, 2014, in New York City from 8:30 a.m. to approximately 1:00 p.m. Eastern … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring […]

Study Shows Promising Results with Novel Approach to Medtronic Cardiac Resynchronization Therapy

[Thomson Reuters ONE] – Late-Breaking Clinical Trial Data Show Implant Success with Pacing Inside the Left Ventricle in Heart Failure Patients MINNEAPOLIS and SAN FRANCISCO – May 9, 2014 – Medtronic, Inc. (NYSE: MDT) today released … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click […]

Boston Scientific gets subpoena over defibrillators

[Reuters] – Medical device maker Boston Scientific Corp said it received a subpoena this week from the Department of Health and Human Services seeking information about the performance of some of its implanted defibrillators. The subpoena, received on Ma moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring […]

Take Two: Recusals Spur Patent-Case Revisions

moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here to view […]

Medtronic Agrees to Settle Certain INFUSE® Bone Graft Product Liability Cases

[Thomson Reuters ONE] – MINNEAPOLIS – MAY 6, 2014 – Medtronic, Inc. (NYSE: MDT) today announced that it has agreed with certain plaintiffs’ counsel to settle their inventories of filed and unfiled product liability claims related … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click […]

Medtronic: One Of The Best Dividend Growth Ideas

moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here to view […]